2018-2023 Global Infectious Diseases Market Report (Status and Outlook)

September 2018 | 133 pages | ID: 25BF83AB8B4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Infectious Diseases market for 2018-2023.

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.
Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.
Over the next five years, LPI(LP Information) projects that Infectious Diseases will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Infectious Diseases market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Antibacterial drugs
• Antiviral drugs
• Antiparasitic drugs

Segmentation by application:

• Acquired Immune Deficiency Syndrome
• Hepatitis B
• Hepatitis C
• Human Papillomavirus
• Hospital acquired Methicillin-resistant Staphylococcus aureus infection
• Chlamydia trachomatis and Neisseria Gonorrhea

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Pfizer
• AbbVie
• Astellas Pharma
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Chimerix Pharmaceuticals
• Cubist
• Eli Lilly
• Isis Pharmaceuticals
• Mitsubishi Tanabe Pharma
• Novartis
• Sanofi
• Vertex   

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Infectious Diseases market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Infectious Diseases market by identifying its various subsegments.
• Focuses on the key global Infectious Diseases players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Infectious Diseases with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Infectious Diseases submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Infectious Diseases Market Size 2013-2023
  2.1.2 Infectious Diseases Market Size CAGR by Region
2.2 Infectious Diseases Segment by Type
  2.2.1 Antibacterial drugs
  2.2.2 Antiviral drugs
  2.2.3 Antifungal drugs
  2.2.4 Antiparasitic drugs
2.3 Infectious Diseases Market Size by Type
  2.3.1 Global Infectious Diseases Market Size Market Share by Type (2013-2018)
  2.3.2 Global Infectious Diseases Market Size Growth Rate by Type (2013-2018)
2.4 Infectious Diseases Segment by Application
  2.4.1 Acquired Immune Deficiency Syndrome
  2.4.2 Hepatitis B
  2.4.3 Hepatitis C
  2.4.4 Human Papillomavirus
  2.4.5 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
  2.4.6 Chlamydia trachomatis and Neisseria Gonorrhea
2.5 Infectious Diseases Market Size by Application
  2.5.1 Global Infectious Diseases Market Size Market Share by Application (2013-2018)
  2.5.2 Global Infectious Diseases Market Size Growth Rate by Application (2013-2018)

3 GLOBAL INFECTIOUS DISEASES BY PLAYERS

3.1 Global Infectious Diseases Market Size Market Share by Players
  3.1.1 Global Infectious Diseases Market Size by Players (2016-2018)
  3.1.2 Global Infectious Diseases Market Size Market Share by Players (2016-2018)
3.2 Global Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFECTIOUS DISEASES BY REGIONS

4.1 Infectious Diseases Market Size by Regions
4.2 Americas Infectious Diseases Market Size Growth
4.3 APAC Infectious Diseases Market Size Growth
4.4 Europe Infectious Diseases Market Size Growth
4.5 Middle East & Africa Infectious Diseases Market Size Growth

5 AMERICAS

5.1 Americas Infectious Diseases Market Size by Countries
5.2 Americas Infectious Diseases Market Size by Type
5.3 Americas Infectious Diseases Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Infectious Diseases Market Size by Countries
6.2 APAC Infectious Diseases Market Size by Type
6.3 APAC Infectious Diseases Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Infectious Diseases by Countries
7.2 Europe Infectious Diseases Market Size by Type
7.3 Europe Infectious Diseases Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Infectious Diseases by Countries
8.2 Middle East & Africa Infectious Diseases Market Size by Type
8.3 Middle East & Africa Infectious Diseases Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL INFECTIOUS DISEASES MARKET FORECAST

10.1 Global Infectious Diseases Market Size Forecast (2018-2023)
10.2 Global Infectious Diseases Forecast by Regions
  10.2.1 Global Infectious Diseases Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Infectious Diseases Forecast by Type
10.8 Global Infectious Diseases Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 F. Hoffmann-La Roche
  11.1.1 Company Details
  11.1.2 Infectious Diseases Product Offered
  11.1.3 F. Hoffmann-La Roche Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 F. Hoffmann-La Roche News
11.2 Gilead Sciences
  11.2.1 Company Details
  11.2.2 Infectious Diseases Product Offered
  11.2.3 Gilead Sciences Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Gilead Sciences News
11.3 GlaxoSmithKline
  11.3.1 Company Details
  11.3.2 Infectious Diseases Product Offered
  11.3.3 GlaxoSmithKline Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 GlaxoSmithKline News
11.4 Johnson & Johnson
  11.4.1 Company Details
  11.4.2 Infectious Diseases Product Offered
  11.4.3 Johnson & Johnson Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Johnson & Johnson News
11.5 Merck
  11.5.1 Company Details
  11.5.2 Infectious Diseases Product Offered
  11.5.3 Merck Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Merck News
11.6 Pfizer
  11.6.1 Company Details
  11.6.2 Infectious Diseases Product Offered
  11.6.3 Pfizer Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Pfizer News
11.7 AbbVie
  11.7.1 Company Details
  11.7.2 Infectious Diseases Product Offered
  11.7.3 AbbVie Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 AbbVie News
11.8 Astellas Pharma
  11.8.1 Company Details
  11.8.2 Infectious Diseases Product Offered
  11.8.3 Astellas Pharma Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Astellas Pharma News
11.9 AstraZeneca
  11.9.1 Company Details
  11.9.2 Infectious Diseases Product Offered
  11.9.3 AstraZeneca Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 AstraZeneca News
11.10 Bayer
  11.10.1 Company Details
  11.10.2 Infectious Diseases Product Offered
  11.10.3 Bayer Infectious Diseases Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Bayer News
11.11 Bristol-Myers Squibb
11.12 Chimerix Pharmaceuticals
11.13 Cubist
11.14 Eli Lilly
11.15 Isis Pharmaceuticals
11.16 Mitsubishi Tanabe Pharma
11.17 Novartis
11.18 Sanofi
11.19 Vertex

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Infectious Diseases
Figure Infectious Diseases Report Years Considered
Figure Market Research Methodology
Figure Global Infectious Diseases Market Size Growth Rate 2013-2023 ($ Millions)
Table Infectious Diseases Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Antibacterial drugs
Table Major Players of Antiviral drugs
Table Major Players of Antifungal drugs
Table Major Players of Antiparasitic drugs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure Global Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure Global Antibacterial drugs Market Size Growth Rate
Figure Global Antiviral drugs Market Size Growth Rate
Figure Global Antifungal drugs Market Size Growth Rate
Figure Global Antiparasitic drugs Market Size Growth Rate
Figure Infectious Diseases Consumed in Acquired Immune Deficiency Syndrome
Figure Global Infectious Diseases Market: Acquired Immune Deficiency Syndrome (2013-2018) ($ Millions)
Figure Global Acquired Immune Deficiency Syndrome YoY Growth ($ Millions)
Figure Infectious Diseases Consumed in Hepatitis B
Figure Global Infectious Diseases Market: Hepatitis B (2013-2018) ($ Millions)
Figure Global Hepatitis B YoY Growth ($ Millions)
Figure Infectious Diseases Consumed in Hepatitis C
Figure Global Infectious Diseases Market: Hepatitis C (2013-2018) ($ Millions)
Figure Global Hepatitis C YoY Growth ($ Millions)
Figure Infectious Diseases Consumed in Human Papillomavirus
Figure Global Infectious Diseases Market: Human Papillomavirus (2013-2018) ($ Millions)
Figure Global Human Papillomavirus YoY Growth ($ Millions)
Figure Infectious Diseases Consumed in Hospital acquired Methicillin-resistant Staphylococcus aureus infection
Figure Global Infectious Diseases Market: Hospital acquired Methicillin-resistant Staphylococcus aureus infection (2013-2018) ($ Millions)
Figure Global Hospital acquired Methicillin-resistant Staphylococcus aureus infection YoY Growth ($ Millions)
Table Global Infectious Diseases Market Size by Application (2013-2018) ($ Millions)
Table Global Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure Global Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure Global Infectious Diseases Market Size in Acquired Immune Deficiency Syndrome Growth Rate
Figure Global Infectious Diseases Market Size in Hepatitis B Growth Rate
Figure Global Infectious Diseases Market Size in Hepatitis C Growth Rate
Figure Global Infectious Diseases Market Size in Human Papillomavirus Growth Rate
Figure Global Infectious Diseases Market Size in Hospital acquired Methicillin-resistant Staphylococcus aureus infection Growth Rate
Figure Global Infectious Diseases Market Size in Chlamydia trachomatis and Neisseria Gonorrhea Growth Rate
Table Global Infectious Diseases Revenue by Players (2016-2018) ($ Millions)
Table Global Infectious Diseases Revenue Market Share by Players (2016-2018)
Figure Global Infectious Diseases Revenue Market Share by Players in 2017
Table Global Infectious Diseases Key Players Head office and Products Offered
Table Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Infectious Diseases Market Size by Regions 2013-2018 ($ Millions)
Table Global Infectious Diseases Market Size Market Share by Regions 2013-2018
Figure Global Infectious Diseases Market Size Market Share by Regions 2013-2018
Figure Americas Infectious Diseases Market Size 2013-2018 ($ Millions)
Figure APAC Infectious Diseases Market Size 2013-2018 ($ Millions)
Figure Europe Infectious Diseases Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Infectious Diseases Market Size 2013-2018 ($ Millions)
Table Americas Infectious Diseases Market Size by Countries (2013-2018) ($ Millions)
Table Americas Infectious Diseases Market Size Market Share by Countries (2013-2018)
Figure Americas Infectious Diseases Market Size Market Share by Countries in 2017
Table Americas Infectious Diseases Market Size by Type (2013-2018) ($ Millions)
Table Americas Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure Americas Infectious Diseases Market Size Market Share by Type in 2017
Table Americas Infectious Diseases Market Size by Application (2013-2018) ($ Millions)
Table Americas Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure Americas Infectious Diseases Market Size Market Share by Application in 2017
Figure United States Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Canada Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Table APAC Infectious Diseases Market Size by Countries (2013-2018) ($ Millions)
Table APAC Infectious Diseases Market Size Market Share by Countries (2013-2018)
Figure APAC Infectious Diseases Market Size Market Share by Countries in 2017
Table APAC Infectious Diseases Market Size by Type (2013-2018) ($ Millions)
Table APAC Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure APAC Infectious Diseases Market Size Market Share by Type in 2017
Table APAC Infectious Diseases Market Size by Application (2013-2018) ($ Millions)
Table APAC Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure APAC Infectious Diseases Market Size Market Share by Application in 2017
Figure China Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Japan Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Korea Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure India Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Australia Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Table Europe Infectious Diseases Market Size by Countries (2013-2018) ($ Millions)
Table Europe Infectious Diseases Market Size Market Share by Countries (2013-2018)
Figure Europe Infectious Diseases Market Size Market Share by Countries in 2017
Table Europe Infectious Diseases Market Size by Type (2013-2018) ($ Millions)
Table Europe Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure Europe Infectious Diseases Market Size Market Share by Type in 2017
Table Europe Infectious Diseases Market Size by Application (2013-2018) ($ Millions)
Table Europe Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure Europe Infectious Diseases Market Size Market Share by Application in 2017
Figure Germany Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure France Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure UK Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Italy Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Russia Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Spain Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Infectious Diseases Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Infectious Diseases Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Infectious Diseases Market Size Market Share by Countries in 2017
Table Middle East & Africa Infectious Diseases Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Infectious Diseases Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Infectious Diseases Market Size Market Share by Type in 2017
Table Middle East & Africa Infectious Diseases Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Infectious Diseases Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Infectious Diseases Market Size Market Share by Application in 2017
Figure Egypt Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Israel Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Infectious Diseases Market Size Growth 2013-2018 ($ Millions)
Figure Global Infectious Diseases arket Size Forecast (2018-2023) ($ Millions)
Table Global Infectious Diseases Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Infectious Diseases Market Size Market Share Forecast by Regions
Figure Americas Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure APAC Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Europe Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure United States Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Canada Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Mexico Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Brazil Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure China Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Japan Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Korea Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure India Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Australia Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Germany Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure France Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure UK Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Italy Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Russia Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Spain Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Egypt Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure South Africa Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Israel Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure Turkey Infectious Diseases Market Size 2018-2023 ($ Millions)
Figure GCC Countries Infectious Diseases Market Size 2018-2023 ($ Millions)
Table Global Infectious Diseases Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Infectious Diseases Market Size Market Share Forecast by Type (2018-2023)
Table Global Infectious Diseases Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Infectious Diseases Market Size Market Share Forecast by Application (2018-2023)
Table F. Hoffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Infectious Diseases Market Share (2016-2018)
Table Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead Sciences Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Gilead Sciences Infectious Diseases Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table GlaxoSmithKline Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure GlaxoSmithKline Infectious Diseases Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Infectious Diseases Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Merck Infectious Diseases Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Pfizer Infectious Diseases Market Share (2016-2018)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure AbbVie Infectious Diseases Market Share (2016-2018)
Table Astellas Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astellas Pharma Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Astellas Pharma Infectious Diseases Market Share (2016-2018)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Infectious Diseases Market Share (2016-2018)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Infectious Diseases Revenue and Gross Margin (2016-2018)
Figure Bayer Infectious Diseases Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Chimerix Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cubist Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Isis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mitsubishi Tanabe Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vertex Basic Information, Head Office, Major Market Areas and Its Competitors